2017
Safety and efficacy of current direct‐acting antiviral regimens in kidney and liver transplant recipients with hepatitis C: Results from the HCV‐TARGET study
Saxena V, Khungar V, Verna EC, Levitsky J, Brown RS, Hassan MA, Sulkowski MS, O'Leary JG, Koraishy F, Galati JS, Kuo AA, Vainorius M, Akushevich L, Nelson DR, Fried MW, Terrault N, Reddy KR. Safety and efficacy of current direct‐acting antiviral regimens in kidney and liver transplant recipients with hepatitis C: Results from the HCV‐TARGET study. Hepatology 2017, 66: 1090-1101. PMID: 28504842, PMCID: PMC5756478, DOI: 10.1002/hep.29258.Peer-Reviewed Original ResearchConceptsSustained virologic responseOmbitasvir/paritaprevir/ritonavirParitaprevir/ritonavirTransplant recipientsLiver transplantKidney transplantAntiviral therapyLarge prospective observational cohort studyChronic hepatitis C virusLiver-kidney transplant recipientsProspective observational cohort studySolid organ transplant recipientsHepatitis C virus (HCV) treatmentBaseline total bilirubinHCV-TARGET studyPrior antiviral therapyAbsence of cirrhosisKidney transplant recipientsLiver transplant recipientsObservational cohort studyOrgan transplant recipientsC virus treatmentGlomerular filtration rateCessation of treatmentSOF/ledipasvir
2010
Racial and insurance disparities in the receipt of transplant among patients with hepatocellular carcinoma
Yu JC, Neugut AI, Wang S, Jacobson JS, Ferrante L, Khungar V, Lim E, Hershman DL, Brown RS, Siegel AB. Racial and insurance disparities in the receipt of transplant among patients with hepatocellular carcinoma. Cancer 2010, 116: 1801-1809. PMID: 20143441, PMCID: PMC3664455, DOI: 10.1002/cncr.24936.Peer-Reviewed Original ResearchConceptsHepatocellular carcinomaAdvanced diseaseCox modelMultivariable logistic regression modelColumbia University Medical CenterReceipt of transplantationPredictors of mortalityAmerican Cancer SocietyUniversity Medical CenterReceipt of transplantLogistic regression modelsLiver transplantTransplant recipientsConsecutive patientsMore patientsBlack patientsHispanic patientsPoor prognosisHCC patientsInsurance statusPoor survivalMedicaid patientsCancer SocietyMedical CenterMedicaid recipients